XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.clinicaltrialsarena.com/news/3-things-to-consider-when-running-a-trial-in-a-med-device-start-up-4847280-2/20%Daily2022-03-22 11:20
https://www.clinicaltrialsarena.com/marketdata/researchreportgeneric-sales-erosion-in-neurology-the-bigger-they-are-the-harder-they-fall-5857458/20%Daily2017-06-30 03:47
https://www.clinicaltrialsarena.com/comment/commentuv-free-tanning-may-prevent-skin-cancer-5857444/20%Daily2017-06-30 03:33
https://www.clinicaltrialsarena.com/news/newscytomx-starts-dosing-in-phase-iii-trial-of-cx-2009-to-treat-solid-tumours-5857345/20%Daily2017-06-29 17:30
https://www.clinicaltrialsarena.com/news/newsastrazeneca-and-chi-med-begin-phase-iii-trial-of-savolitinib-for-prcc-5857360/20%Daily2017-06-29 17:30
https://www.clinicaltrialsarena.com/news/newsniaid-funded-trial-shows-use-of-common-antimicrobials-for-mrsa-abscesses-5857374/20%Daily2017-06-29 17:30
https://www.clinicaltrialsarena.com/news/newsdeals-this-week-selecta-biosciences-bluebird-bio-transgenic-5857419/20%Daily2017-06-29 17:30
https://www.clinicaltrialsarena.com/news/newsmas-this-week-nantcell-shanghai-no1-pharmacy-5857427/20%Daily2017-06-29 17:30
https://www.clinicaltrialsarena.com/news/companies-advance-automated-electronic-alert-systems-for-early-sepsis-recognition-and-treatment-guidance-5853465-2/20%Daily2018-07-18 12:04
https://www.clinicaltrialsarena.com/news/newsmabvax-begins-dosing-of-mvt-1075-in-phase-i-cancer-therapy-trial-5855755/20%Daily2017-06-28 17:30
https://www.clinicaltrialsarena.com/news/newsgenkyotex-starts-enrolment-in-phase-ii-trial-of-gkt831-to-treat-pbc-5855766/20%Daily2017-06-28 17:30
https://www.clinicaltrialsarena.com/news/newsgemphire-reports-positive-top-line-results-from-phase-iib-trial-of-hofh-drug-5856108/20%Daily2017-06-28 17:30
https://www.clinicaltrialsarena.com/comment/commentmercks-oral-multiple-sclerosis-therapy-cladribine-finally-gains-support-from-eu-panel-5856682/20%Daily2017-06-28 17:30
https://www.clinicaltrialsarena.com/comment/commentsanofi-poised-for-explosive-growth-in-global-dermatology-market-5855106/20%Daily2017-06-28 08:35
https://www.clinicaltrialsarena.com/news/industry-viewpoints-the-keys-to-running-a-start-up-med-device-company-5852854-2/20%Daily2018-07-18 12:08
https://www.clinicaltrialsarena.com/news/newssitka-biopharma-to-initiate-phase-i-trial-of-stk-01-to-treat-bladder-cancer-5854331/20%Daily2017-06-27 17:30
https://www.clinicaltrialsarena.com/news/newsverona-to-study-rpl554-in-phase-iib-trial-for-copd-in-five-european-countries-5854339/20%Daily2017-06-27 17:30
https://www.clinicaltrialsarena.com/news/newsteva-and-xenons-phase-ii-trial-of-tv-45070-for-phn-fails-to-meet-endpoints-5854455/20%Daily2017-06-27 17:30
https://www.clinicaltrialsarena.com/comment/commenteular-2017-biosimilars-in-rheumatology-a-painful-conundrum-5853866/20%Daily2017-06-27 09:48
https://www.clinicaltrialsarena.com/news/case-study-learnings-and-challenges-of-conducting-human-factor-studies-on-inhaler-devices-5852797-2/20%Daily2018-07-18 12:09
https://www.clinicaltrialsarena.com/news/newsdurect-concludes-enrolment-in-persist-trial-of-non-opioid-analgesic-5853193/20%Daily2017-06-26 17:30
https://www.clinicaltrialsarena.com/news/newsxenetic-bio-enrols-first-patient-in-phase-ii-trial-of-xbio-101-for-endometrial-cancer-5853197/20%Daily2017-06-26 17:30
https://www.clinicaltrialsarena.com/news/newsgenentech-and-epizyme-to-study-tazemetostat-in-phase-ibii-combination-trial-for-nsclc-5853438/20%Daily2017-06-26 17:30
https://www.clinicaltrialsarena.com/comment/commentcould-a-virus-save-your-life-5852832/20%Daily2017-06-26 06:38
https://www.clinicaltrialsarena.com/comment/commentbiosimilar-drugs-us-trumped-but-fda-addresses-the-issues-5852831/20%Daily2017-06-26 06:36
https://www.clinicaltrialsarena.com/news/announcing-medical-devices-week-on-clinical-trials-arena-5853329-2/20%Daily2018-07-18 12:06
https://www.clinicaltrialsarena.com/news/newsdelmar-pharma-to-initiate-phase-iii-trial-of-val-083-to-treat-gbm-5852471/20%Daily2017-06-25 17:30
https://www.clinicaltrialsarena.com/news/newsbial-and-eisai-report-positive-results-from-phase-ii-trial-of-zebinix-for-epilepsy-5852486/20%Daily2017-06-25 17:30
https://www.clinicaltrialsarena.com/comment/commentdo-new-diabetes-discoveries-deliver-more-benefits-than-risks-5852839/20%Daily2017-06-25 17:30
https://www.clinicaltrialsarena.com/comment/commentbotanical-healing-power-does-the-cure-for-anemia-really-grow-on-trees-5852850/20%Daily2017-06-25 17:30
https://www.clinicaltrialsarena.com/news/how-do-you-define-risk-based-monitoring-5852564-2/20%Daily2018-09-25 07:39
https://www.clinicaltrialsarena.com/comment/commentcarefully-stepping-away-from-rcts-clinical-trial-design-in-a-new-medical-era-5851855/20%Daily2017-06-23 03:51
https://www.clinicaltrialsarena.com/news/newsdeals-this-week-dova-pharmaceuticals-inc-gamida-cell-ltd-onxeo-sa-5850110/20%Daily2017-06-22 17:30
https://www.clinicaltrialsarena.com/news/newsmas-this-week-shanghai-chempartner-co-ltd-cell-medica-ltd-bbi-group-holding-ltd-5850717/20%Daily2017-06-22 17:30
https://www.clinicaltrialsarena.com/news/newsctd-holdings-starts-enrolment-in-phase-iii-trial-of-trappsol-cyclo-for-npc-5851717/20%Daily2017-06-22 17:30
https://www.clinicaltrialsarena.com/news/newschi-med-commences-phase-iii-trial-of-hmpl-453-for-solid-tumours-5851726/20%Daily2017-06-22 17:30
https://www.clinicaltrialsarena.com/news/newsnovartis-reports-positive-top-line-data-from-phase-iii-trial-of-cardiovascular-drug-5852177/20%Daily2019-08-09 08:29
https://www.clinicaltrialsarena.com/comment/commentcould-novartis-longer-acting-anti-vegf-drug-rth258-offset-lucentis-loss-to-eylea-5852533/20%Daily2017-06-22 17:30
https://www.clinicaltrialsarena.com/news/challenges-and-opportunities-of-patient-reported-outcome-instruments-in-clinical-trials-perspectives-from-a-pro-scientist-5851193-2/20%Daily2018-08-15 13:17
https://www.clinicaltrialsarena.com/marketdata/researchreportrisk-of-venous-thromboembolism-higher-in-ageing-population-5851039/20%Daily2017-06-22 07:22
https://www.clinicaltrialsarena.com/news/newsimmune-pharma-starts-enrolment-in-phase-iii-trial-of-ceplene-for-cmml-5850240/20%Daily2017-06-21 17:30
https://www.clinicaltrialsarena.com/news/newsindex-initiates-enrolment-for-phase-iib-trial-of-cobitolimod-to-treat-ulcerative-colitis-5850250/20%Daily2017-06-21 17:30
https://www.clinicaltrialsarena.com/news/newsnew-phase-iii-trial-indicates-positive-outcome-for-astellas-cancer-drug-5850404/20%Daily2017-06-21 17:30
https://www.clinicaltrialsarena.com/research-reports/researchreporther2-expression-associated-with-poorer-prognosis-but-found-more-frequently-in-non-invasive-breast-cancer-5850733/20%Daily2017-06-21 17:30
https://www.clinicaltrialsarena.com/news/biomarker-driven-clinical-trial-gives-keytruda-the-lead-in-the-immuno-oncology-drug-race-5841396-2/20%Daily2018-07-18 12:12
https://www.clinicaltrialsarena.com/news/newsgenexine-to-start-phase-ibii-combination-trial-of-cervical-cancer-drug-gx-188e-5849036/20%Daily2017-06-20 17:30
https://www.clinicaltrialsarena.com/news/newshansa-medical-begins-ides-dosing-in-phase-ii-trial-for-anti-gbm-antibody-disease-5849044/20%Daily2017-06-20 17:30
https://www.clinicaltrialsarena.com/comment/commentneupsig-2017-three-strategies-for-improving-treatment-options-for-neuropathic-pain-5849247/20%Daily2017-06-20 17:30
https://www.clinicaltrialsarena.com/comment/commentneupsig-2017-sodium-channel-blockers-highlight-a-new-approach-to-neuropathic-pain-5849300/20%Daily2017-06-20 17:30
https://www.clinicaltrialsarena.com/news/newseffector-pfizer-and-merck-to-initiate-phase-ii-combination-trial-for-colorectal-cancer-5849391/20%Daily2017-06-20 17:30
https://www.clinicaltrialsarena.com/comment/commentinsulin-related-therapy-despite-advances-unmet-needs-remain-5847907/20%Daily2017-06-20 04:12
https://www.clinicaltrialsarena.com/news/leveraging-emerging-technologies-to-enhance-the-supply-chain-5841342-2/20%Daily2018-07-18 12:13
https://www.clinicaltrialsarena.com/news/newsgsks-benlysta-shows-positive-outcome-in-phase-ii-continuation-trial-for-sle-5847710/20%Daily2017-06-19 17:30
https://www.clinicaltrialsarena.com/news/newssynlogic-begins-dosing-in-phase-i-trial-of-synb1020-to-treat-hyperammonemia-5847714/20%Daily2017-06-19 17:30
https://www.clinicaltrialsarena.com/news/newsseattle-genetics-stops-phase-iii-trial-of-leukaemia-drug-due-to-high-death-rate-5848223/20%Daily2017-06-19 17:30
https://www.clinicaltrialsarena.com/comment/commenteular-2017-lupus-community-remains-divided-on-outcome-measures-5846647/20%Daily2017-06-19 04:06
https://www.clinicaltrialsarena.com/news/newsgalera-enrols-last-patient-in-phase-iib-trial-of-gc4419-to-treat-oral-mucositis-5846549/20%Daily2017-06-18 17:30
https://www.clinicaltrialsarena.com/news/newsnovartis-reports-favourable-data-from-phase-iii-extension-trial-of-cosentyx-for-as-5846564/20%Daily2017-06-18 17:30
https://www.clinicaltrialsarena.com/news/newsxencor-reports-interim-positive-results-from-phase-ii-trial-of-xmab5871-for-igg4-rd-5846918/20%Daily2017-06-18 17:30
https://www.clinicaltrialsarena.com/news/4-tips-to-consider-when-hiring-clinical-trial-personnel_-5845742-2/20%Daily2018-07-18 12:11
https://www.clinicaltrialsarena.com/news/newsdeals-this-week-vertos-medical-kiadis-pharma-oxis-international-5845016/20%Daily2021-11-26 04:20
https://www.clinicaltrialsarena.com/news/newsmas-this-week-csl-limited-sunflower-pharmaceutical-group-co-ltd-immunotech-laboratories-inc-5845064/20%Daily2017-06-15 17:30
https://www.clinicaltrialsarena.com/news/newshelsinn-and-mei-begin-dosing-in-phase-ii-combination-trial-to-treat-mds-5845202/20%Daily2017-06-15 17:30
https://www.clinicaltrialsarena.com/news/newsredhill-biopharma-commences-phase-iii-trial-of-rhb-105-to-treat-h-pylori-infection-5845218/20%Daily2017-06-15 17:30
https://www.clinicaltrialsarena.com/news/newsjanssen-reports-positive-long-term-results-from-phase-iii-trial-of-sirukumab-for-ra-5845428/20%Daily2017-06-15 17:30
https://www.clinicaltrialsarena.com/news/tackling-drug-non-compliance-part-ii-5841329-2/20%Daily2018-09-11 07:21
https://www.clinicaltrialsarena.com/news/newsthreshold-pharma-begins-dosing-of-cancer-drugs-evofosfamide-and-ipilimumab-in-phase-i-trial-5843813/20%Daily2017-06-14 17:30
https://www.clinicaltrialsarena.com/news/newsmodra-pharma-starts-enrolment-in-phase-ii-trial-of-modradoc006r-for-prostate-cancer-5843821/20%Daily2017-06-14 17:30
https://www.clinicaltrialsarena.com/news/newsnew-oxford-study-indicates-bleeding-risk-by-aspirin-in-elderly-patients-5844245/20%Daily2017-06-14 17:30
https://www.clinicaltrialsarena.com/comment/commentfecal-transplant-based-treatment-for-c-difficile-reaches-phase-iii-trials-5844316/20%Daily2017-06-14 17:30
https://www.clinicaltrialsarena.com/comment/commenteular-2017-chondroitin-sulphate-surprises-with-disease-modifying-effect-in-knee-osteoarthritis-patients-5844715/20%Daily2017-06-14 17:30
https://www.clinicaltrialsarena.com/news/tackling-drug-non-compliance-part-i-5841319-2/20%Daily2018-09-11 07:21
https://www.clinicaltrialsarena.com/news/newsboehringer-and-lilly-to-assess-empagliflozin-for-chronic-kidney-disease-5842615/20%Daily2017-06-13 17:30
https://www.clinicaltrialsarena.com/news/newstigenix-initiates-phase-iii-trial-of-cx601-to-treat-perianal-fistulas-5842627/20%Daily2017-06-13 17:30
https://www.clinicaltrialsarena.com/news/newsjanssen-reports-positive-results-from-canvas-programme-of-canagliflozin-5842958/20%Daily2017-06-13 17:30
https://www.clinicaltrialsarena.com/news/sink-or-swim-the-need-for-industry-to-embrace-new-technology-5840846-2/20%Daily2018-07-18 12:16
https://www.clinicaltrialsarena.com/news/newssanofi-and-regenerons-two-phase-iiibiv-trials-of-alirocumab-meet-primary-endpoint-5841302/20%Daily2017-06-12 17:30
https://www.clinicaltrialsarena.com/news/newsseres-begins-phase-iii-trial-of-ser-109-to-treat-recurrent-c-difficile-infection-5841315/20%Daily2017-06-12 17:30
https://www.clinicaltrialsarena.com/news/newsgsk-and-mmv-report-positive-headline-results-from-two-phase-iii-trials-of-tafenoquine-5841656/20%Daily2017-06-12 17:30
https://www.clinicaltrialsarena.com/news/newsinovio-initiates-phase-iii-trial-of-vgx-3100-to-treat-hpv-related-cervical-pre-cancer-5840016/20%Daily2017-06-11 17:30
https://www.clinicaltrialsarena.com/news/newslexicons-phase-iii-trial-of-sotagliflozin-for-type-1-diabetes-meets-primary-endpoint-5840026/20%Daily2017-06-11 17:30
https://www.clinicaltrialsarena.com/news/newsmerck-and-pfizer-report-positive-results-from-two-phase-iii-trials-of-ertugliflozin-5840359/20%Daily2017-06-11 17:30
https://www.clinicaltrialsarena.com/news/industry-viewpoints-an-insight-into-running-trials-in-south-africa-5833268-2/20%Daily2018-07-18 12:17
https://www.clinicaltrialsarena.com/news/newsdeals-this-week-marina-biotech-inc-strekin-ag-h-lundbeck-as-5837524/20%Daily2017-06-08 17:30
https://www.clinicaltrialsarena.com/news/newsmas-this-week-ucb-pharma-ltd-china-meheco-co-ltd-5837979/20%Daily2017-06-08 17:30
https://www.clinicaltrialsarena.com/news/newshitachi-and-md-anderson-to-investigate-impt-vs-imrt-for-oropharyngeal-cancer-5838348/20%Daily2017-06-08 17:30
https://www.clinicaltrialsarena.com/news/newsalkermes-commences-phase-iii-trial-of-alks-3831-in-young-adults-with-schizophrenia-5838366/20%Daily2017-06-08 17:30
https://www.clinicaltrialsarena.com/news/newsaveo-oncologys-tivozanib-enters-phase-ii-part-of-tinivo-trial-for-rcc-5838467/20%Daily2017-06-08 17:30
https://www.clinicaltrialsarena.com/news/brexit-and-the-impact-on-clinical-research-5833157-2/20%Daily2018-07-18 12:18
https://www.clinicaltrialsarena.com/news/newsalectinib-and-dacomitinib-show-potential-in-separate-trials-for-lung-cancer-5836992/20%Daily2017-06-07 17:30
https://www.clinicaltrialsarena.com/news/newspsoriasis-drug-demonstrates-positive-outcome-in-two-phase-iii-trials-5837002/20%Daily2017-06-07 17:30
https://www.clinicaltrialsarena.com/news/newsarqule-begins-dosing-of-arq-092-in-phase-iii-trial-for-overgrowth-diseases-5837199/20%Daily2017-06-07 17:30
https://www.clinicaltrialsarena.com/news/how-to-improve-cts-management-5833096-2/20%Daily2018-07-18 12:19
https://www.clinicaltrialsarena.com/comment/commenttempered-optimism-for-early-ido-pd1-dual-checkpoint-blockade-data-in-advanced-urothelial-carcinoma-5835840/20%Daily2017-06-07 03:57
https://www.clinicaltrialsarena.com/news/newsprostate-cancer-trial-shows-improved-survival-with-additional-hormone-therapy-5835746/20%Daily2017-06-06 17:30
https://www.clinicaltrialsarena.com/news/newsnew-phase-iii-trial-of-mv-chikv-for-chikungunya-begins-enrolment-5835765/20%Daily2017-06-06 17:30
https://www.clinicaltrialsarena.com/news/newsjanssen-reports-positive-follow-up-data-from-phase-iii-trial-of-imbruvica-for-cll-5835774/20%Daily2017-06-06 17:30
https://www.clinicaltrialsarena.com/comment/commentcan-survival-data-weaken-the-gold-standard-use-of-cdk46-inhibitors-5835087/20%Daily2017-06-06 10:41
https://www.clinicaltrialsarena.com/news/increment-study-data-question-effectiveness-of-combination-antibiotic-therapy-in-certain-patients-5833077-2/20%Daily2018-07-18 12:20
https://www.clinicaltrialsarena.com/news/newsmorphosys-initiates-phase-iii-trial-of-mor208-bendamustine-for-dlbcl-5834056/20%Daily2017-06-05 17:30
https://www.clinicaltrialsarena.com/news/newsnew-ovarian-cancer-drug-found-to-shrink-tumours-in-7-of-15-women-5834062/20%Daily2019-08-09 08:37
https://www.clinicaltrialsarena.com/news/newsjanssen-reports-positive-results-from-two-phase-iii-combination-trials-of-darzalex-5834074/20%Daily2017-06-05 17:30
https://www.clinicaltrialsarena.com/comment/commentadding-monoclonal-antibodies-to-induction-regimens-questions-remain-5833178/20%Daily2017-06-05 04:16
https://www.clinicaltrialsarena.com/news/the-top-5-may-2017-5833058-2/20%Daily2018-07-18 12:21
https://www.clinicaltrialsarena.com/analysis/featuremays-top-stories-funders-ngos-agree-on-new-trial-standards-actinogens-xanamem-in-phase-ii-5825756/20%Daily2017-06-04 17:30
https://www.clinicaltrialsarena.com/news/newsocera-doses-first-patient-in-phase-iia-trial-of-ocr-002-to-treat-cirrhosis-5832902/20%Daily2017-06-04 17:30
https://www.clinicaltrialsarena.com/news/newsseattle-genetics-to-study-adcetris-in-phase-iii-combination-trial-to-treat-hl-5832914/20%Daily2017-06-04 17:30
https://www.clinicaltrialsarena.com/news/newsastrazenecas-lynparza-shows-positive-outcome-in-phase-iii-trial-for-ovarian-cancer-5833276/20%Daily2017-06-04 17:30
https://www.clinicaltrialsarena.com/news/financing-small-companies-strategies-to-fund-clinical-trials-with-limited-resources-5832651-2/20%Daily2018-07-18 12:23
https://www.clinicaltrialsarena.com/news/newsalzheimers-drug-candidate-shows-positive-outcome-in-phase-ii-trial-for-down-syndrome-5831740/20%Daily2022-03-23 08:34
https://www.clinicaltrialsarena.com/news/newsinovio-to-assess-new-t-cell-therapy-in-phase-ibii-combination-trial-for-bladder-cancer-5831747/20%Daily2017-06-01 17:30
https://www.clinicaltrialsarena.com/news/newsdeals-this-week-lakepharma-inc-array-biopharma-inc-galenica-ltd-5831810/20%Daily2017-06-01 17:30
https://www.clinicaltrialsarena.com/news/newsmas-this-week-chiltern-international-ltd-sysmex-corporation-5831816/20%Daily2017-06-01 17:30
https://www.clinicaltrialsarena.com/news/newsvaxon-reports-positive-data-from-phase-iib-trial-of-vx-001-to-treat-nsclc-5832111/20%Daily2017-06-01 17:30
https://www.clinicaltrialsarena.com/comment/commentstivarga-is-the-first-fda-approved-targeted-treatment-for-liver-cancer-in-a-decade-5831481/20%Daily2017-06-01 08:37
https://www.clinicaltrialsarena.com/news/industry-viewpoints-how-to-manage-all-aspects-of-the-clinical-supply-chain-5828412-2/20%Daily2018-07-18 12:24